Comparator drug sourcing in the EU is shaped by a defined set of availability, regulatory, competitive, and logistical pressures, alongside practical strategies to reduce risk and protect trial timelines.
Syed Fazle Rob, RPh
Advertisement
Head of Global Business development, AF Pharma Distribuce léčiv s.r.o.
Articles by Syed Fazle Rob, RPh
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Control Plane for Agentic Clinical Operations: Governing Autonomous Digital Actors in Regulated Trials
2
HHS Launches SURPASS Program and Three Complementary Initiatives to Transform Clinical Trial Design and Infrastructure
3
Where AI Leads in Trial Design—and Where Humans Still Need To
4
Hierarchical Endpoints in Cardiology: How Much Treatment Benefit, and From Where
5